...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Medicine. >Effectiveness comparison of a Chinese dicitraditionalmene formula Wuzi Yanzong Pill and its analogous prescriptions for the treatment of oligoasthenozoospermia: A systematic review and meta-analysis protocol
【24h】

Effectiveness comparison of a Chinese dicitraditionalmene formula Wuzi Yanzong Pill and its analogous prescriptions for the treatment of oligoasthenozoospermia: A systematic review and meta-analysis protocol

机译：中药传统配方五物衍宗丸及其类似处方治疗少突肌少精症的疗效比较：系统评价和荟萃分析

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Among male sterility factors, oligoasthenozoospermia is the most common. As people's lifestyle changes and the population ages, the incidence of oligoasthenozoospermia continues to increase. The studies have shown that about 15% of married couples in the world are affected by infertility, among which infertility caused by male factors alone accounts for about 50%. Many clinical trials have proven that Wuzi Yanzong Pill has a significant effect in the treatment of oligoasthenozoospermia . In this systematic review , we aim to evaluate the effectiveness and safety of Wuzi Yanzong Pill for oligoasthenozoospermia . Methods: We will search for PubMed, Cochrane Library, AMED, EMbase, WorldSciNet; Nature, Science online, and China Journal Full-text Database (CNKI), China Biomedical Literature CD-ROM Database (CBM), and related randomized controlled trials included in the China Resources Database. The time is limited from the construction of the library to April 2019. We will use the criteria provided by Cochrane 5.1.0 for quality assessment and risk assessment of the included studies, and use the Revman 5.3 and Stata13.0 software for meta-analysis of the effectiveness, recurrence rate, and symptom scores of oligoasthenozoospermia . Ethics and dissemination: This systematic review will evaluate the efficacy and safety of Wuzi Yanzong Pill for treating oligoasthenozoospermia . Because all of the data used in this systematic review and meta-analysis has been published, this review does not require ethical approval. Furthermore, all data will be analyzed anonymously during the review process Trial.
机译：背景：在男性不育因素中，少精子症少精子症最常见。随着人们生活方式的改变和人口的老龄化，少精子症精子症的发生率持续增加。研究表明，全球约有15％的已婚夫妇患有不孕症，其中仅由男性因素引起的不孕症约占50％。许多临床试验证明，乌子盐宗丸对少精症精子症有明显的治疗作用。在本系统的审查中，我们的目的是评估乌子盐宗丸治疗少精子症精子症的有效性和安全性。方法：我们将搜索PubMed，Cochrane图书馆，AMED，EMbase，WorldSciNet; 《自然》，《在线》和《中国期刊》全文数据库（CNKI），《中国生物医学文献》光盘数据库（CBM）以及《华润数据库》中包含的相关随机对照试验。从库的建设到2019年4月，时间是有限的。我们将使用Cochrane 5.1.0提供的标准进行纳入研究的质量评估和风险评估，并使用Revman 5.3和Stata13.0软件进行荟萃分析。少精子症精子症的疗效，复发率和症状评分伦理与传播：本系统综述将评估乌孜延宗丸治疗少精子症精子症的疗效和安全性。由于本系统评价和荟萃分析中使用的所有数据均已发布，因此本评价不需要道德上的认可。此外，所有数据将在审阅过程中进行匿名分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号